MedTrace Logo

Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Major Depressive Disorder

NCT07282678 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 214

Last updated 2025-12-17

No results posted yet for this study

Summary

The purpose of this research study is to investigate a closed-loop transcranial alternating current stimulation (tACS) device to evaluate its ability to reduce symptoms of major depressive disorder

Conditions

  • Depression - Major Depressive Disorder
  • Transcranial Alternating Current Stimulation

Interventions

DEVICE

Closed-loop tACS

Individual alpha tACS

DEVICE

Sham Comparator

Sham stimulation

Sponsors & Collaborators

  • Pulvinar Neuro, LLC

    lead INDUSTRY

Principal Investigators

  • Mark George, MD · Medical University of South Carolina

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-31
Primary Completion
2027-12-31
Completion
2028-01-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07282678 on ClinicalTrials.gov